These Two Biotechs Offer Stability in a Crazy Market
A slow and steady approach with these stable biopharma stocks offers refuge from a market that feels ready to pop.
A slow and steady approach with these stable biopharma stocks offers refuge from a market that feels ready to pop.
The airline turned some heads on Wall Street while “executing from a position of strength.”
Let’s discuss Visa’s latest U.S. Spending Index and what we’ll be watching next week.
We’re taking a closer look at the defense contractor following a recent peak.
Momentum in the banking sector is building just as the biggest names in the industry are preparing to report earnings.
Pepsi lost its fizz years ago — and this quarter didn’t change that.
Shares in the Korean semiconductor firm are set to list on Friday and raise a record amount for a company based outside of the U.S.
It’s been tough to get on board this name but now there is finally an opportunity.
The firm cut guidance and then announced a pivot, so we’re going to trim the position before entering the red.
The market is in a transitional phase as we await earnings.